Immunotherapy and Cancer: Reality and Hopes
venerd́ 03 luglio 2015
venerd́ 03 luglio 2015
09:20 - 11:10
Session I
M. Maio
The evolving role of immunotherapy in cancer treatment
A. Rossi
Appropriate response evaluation criteria
F. Perrone
Methodology of clinical trials
11:30 - 13:00
Session II
P. Ascierto
Immunotherapy of melanoma: a successful example
M. Barberis
Predictive biomarkers in immunotherapy: pitfall and reality
A. Passaro
Immunotherapy - related toxicity and its management
14:00 - 16:00
Session III - NSCLC
J. Brahmer
Anti PD-1: phase I-II trials
N.A. Rizvi
Anti PD-1: phase III studies
B. Besse
The role of anti PD-L1
E. Felip
Combination of immunotherapy and targeted therapies in biomarkers-driven disease
16:00 - 17:00
Session IV ( All Faculty Session III members)
Advanced NSCLC: building together a treatment algorithm in the check-point inhibitors era